Holen Sie sich die Stockscreener-App
15.60
1.70%
-0.27
Handel nachbörslich:
15.53
-0.07
-0.45%
Schlusskurs vom Vortag:
$15.87
Offen:
$16.09
24-Stunden-Volumen:
880.42K
Relative Volume:
0.89
Marktkapitalisierung:
$762.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-695.98M
KGV:
-0.0475
EPS:
-328.6331
Netto-Cashflow:
$-143.65M
1W Leistung:
-0.92%
1M Leistung:
+15.47%
6M Leistung:
-48.38%
1J Leistung:
+11.43%
1-Tages-Spanne:
$15.41
$16.15
1-Wochen-Bereich:
$15.20
$16.55
52-Wochen-Spanne:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Firmenname
Vor Biopharma Inc
Sektor
Branche
Telefon
617-655-6580
Adresse
500 BOYLSTON STREET, BOSTON
Compare VOR vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
15.60 | 775.21M | 0 | -695.98M | -143.65M | -328.63 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Eingeleitet | Jefferies | Buy |
| 2026-03-19 | Eingeleitet | Wells Fargo | Overweight |
| 2026-01-09 | Eingeleitet | Citigroup | Buy |
| 2025-12-17 | Eingeleitet | TD Cowen | Buy |
| 2025-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2025-11-25 | Fortgesetzt | Wedbush | Neutral |
| 2025-10-15 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-06-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Eingeleitet | Wedbush | Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Neutral |
| 2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-12-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-03-03 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Sell |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Ra Capital Management, L.P. Sells 530,610 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
RA Capital sells Vor Biopharma (VOR) shares worth $11.8 million - Investing.com
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 153,735 Shares of Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $858,840.44 in Stock - MarketBeat
RA Capital reports 19.9% Vor Biopharma (VOR) stake after share sales - Stock Titan
H.C. Wainwright lowers Vor Biopharma price target to $31 By Investing.com - Investing.com Australia
HC Wainwright Has Lowered Expectations for Vor Biopharma (NASDAQ:VOR) Stock Price - MarketBeat
VOR Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $31 - GuruFocus
Vor Biopharma, Inc. (VOR) PT Lowered to $31 at H.C. Wainwright - StreetInsider
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Up 66.5% in March - MarketBeat
Vor Biopharma(VOR.US) 10% Shareholder Sells US$10.23 Million in Common Stock - Moomoo
Ra capital sells Vor Biopharma (VOR) shares worth $10.2 million By Investing.com - Investing.com India
Vor Biopharma (NASDAQ:VOR) Director Sells $2,242,984.59 in Stock - MarketBeat
Ra Capital Management, L.P. Sells 484,104 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $13,041.00 in Stock - MarketBeat
Ra capital sells Vor Biopharma (VOR) shares worth $10.2 million - Investing.com
RA Capital trims Vor Biopharma (VOR) stake while keeping 19.9% ownership - Stock Titan
RA Capital Healthcare Fund trims Vor Biopharma (NASDAQ: VOR) stake, still holds 3.9M shares - Stock Titan
VOR Forecast, Price Target & Analyst Ratings | VOR BIOPHARMA INC (NASDAQ:VOR) - ChartMill
Vor Biopharma (VOR) Financials 2026Income Statement and Balance Sheet $VOR - MarketBeat
Vor Biopharma (VOR) CMO discloses options and RSU-based stake - Stock Titan
Dow Update: What are analysts price targets for Vor Biopharma IncEarnings Recap Report & Precise Trade Entry Recommendations - baoquankhu1.vn
RA Capital (NASDAQ: VOR) discloses 19.9% Vor Biopharma ownership cap - Stock Titan
Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR) - Seeking Alpha
Bull Bear: What are analysts price targets for Vor Biopharma IncMarket Risk Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Stifel reiterates Vor Biopharma stock rating on drug potential By Investing.com - Investing.com India
Stifel reiterates Vor Biopharma stock rating on drug potential - Investing.com
Vor Biopharma (VOR) Reiterated at Buy by Stifel After Meetings About Telitacicept Potential - StreetInsider
Aug Wrap: Should you buy the dip on Vor Biopharma Inc2026 Performance Recap & Fast Moving Market Watchlists - baoquankhu1.vn
Aug Momentum: Is Vor Biopharma Inc currently under institutional pressure2026 Recap & Daily Oversold Bounce Ideas - baoquankhu1.vn
Vor Biopharma (NASDAQ:VOR) Shares Gap Down on Insider Selling - MarketBeat
Vor Biopharma(VOR.US) 10% Shareholder Sells US$14.52 Million in Common Stock - Moomoo
Ra capital sells Vor Biopharma (VOR) shares worth $14.5 million By Investing.com - Investing.com Canada
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 260,000 Shares of Stock - MarketBeat
Ra capital sells Vor Biopharma (VOR) shares worth $14.5 million - Investing.com
RA Capital trims Vor Biopharma (VOR) stake with 849K-share sale - Stock Titan
Vor Biopharma (NASDAQ:VOR) Trading Down 5.8%Here's Why - marketbeat.com
Wall Street analysts predict a 107.82% upside in Vor Biopharma (VOR): Here's what you should know - MSN
Vor Biopharma Inc. (NASDAQ:VOR) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 589,257 Shares of Stock - MarketBeat
Vor Biopharma (VOR) upgraded to buy: Here's why - MSN
Wall Street Zen Upgrades Vor Biopharma (NASDAQ:VOR) to Hold - MarketBeat
Jefferies initiates coverage of Vor Biopharma (VOR) with buy recommendation - MSN
Vor Biopharma (VOR) Upgraded to Buy: Here's Why - Yahoo Finance
Wall Street experts anticipate that Vor Biopharma (VOR) could surge by 107.82%: Key Information You Need to Know - bitget.com
Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know - Yahoo Finance
Chen Yu and TCG entities hold 10.5% of Vor Biopharma (NASDAQ: VOR) - Stock Titan
TCG Crossover funds in Vor (VOR) disclose 2,836,539 common shares - Stock Titan
Vor Biopharma (VOR) ownership update shows RA Capital at 19.9% - Stock Titan
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vor Bio announces $75M private placement - MSN
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):